NCT00003266 2023-06-18
Methylphenidate in Treating Patients With Melanoma
Eastern Cooperative Oncology Group
Phase 3 Completed
Clinical Trials
10 trialsNCT00424099 2023-06-01
Methylphenidate and a Nursing Telephone Intervention for Fatigue
M.D. Anderson Cancer Center
Phase 2/3 Completed
NCT05041946 2022-09-29
Patient Controlled Methylphenidate for Cancer Related Fatigue: A Double Blind, Randomized, Placebo Controlled Trial
M.D. Anderson Cancer Center
Phase 3 Completed
NCT02361125 2022-01-04
Patient Controlled Administration of Methylphenidate for Cancer Related Fatigue - PRN Methylphenidate
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00576472 2017-05-30
Learning Impairments Among Survivors of Childhood Cancer
St. Jude Children's Research Hospital
Phase 4 Completed
NCT00376675 2016-08-01
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00129467 2015-04-24
Methylphenidate for Depressed Cancer Patients Receiving Palliative Care
VA Office of Research and Development
Phase NA Completed
NCT00169611 2011-01-27
NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate
Hospices Civils de Lyon
Phase 4 Completed
NCT00758407 2010-01-13
EMF
Medice Arzneimittel Pütter GmbH & Co KG
Phase 2/3 Completed
NCT00138138 2007-12-10
Psychostimulants for Fatigue in Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed